{
    "organizations": [],
    "uuid": "3f1a86fe9089dad0e20d7b9b0dd7431091e80007",
    "author": "cnbc.com",
    "url": "https://www.cnbc.com/2018/05/14/the-associated-press-atyr-pharma-1q-earnings-snapshot.html",
    "ord_in_thread": 0,
    "title": "Atyr Pharma: 1Q Earnings Snapshot",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "SAN DIEGO (AP) _ Atyr Pharma Inc. (LIFE) on Monday reported a loss of $10.7 million in its first quarter.\nOn a per-share basis, the San Diego-based company said it had a loss of 36 cents.\nThe results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 35 cents per share.\nThe company's shares closed at $2.30. A year ago, they were trading at $3.25.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on LIFE at https://www.zacks.com/ap/LIFE",
    "published": "2018-05-14T14:49:00.000+03:00",
    "crawled": "2018-05-15T11:49:31.053+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "san",
        "diego",
        "ap",
        "atyr",
        "pharma",
        "life",
        "monday",
        "reported",
        "loss",
        "million",
        "first",
        "quarter",
        "basis",
        "san",
        "company",
        "said",
        "loss",
        "cent",
        "result",
        "meet",
        "wall",
        "street",
        "expectation",
        "average",
        "estimate",
        "three",
        "analyst",
        "surveyed",
        "zacks",
        "investment",
        "research",
        "loss",
        "cent",
        "per",
        "share",
        "company",
        "share",
        "closed",
        "year",
        "ago",
        "trading",
        "story",
        "generated",
        "automated",
        "insight",
        "http",
        "using",
        "data",
        "zacks",
        "investment",
        "research",
        "access",
        "zacks",
        "stock",
        "report",
        "life",
        "http"
    ]
}